From 2014 to 2020, we compiled radiocarbon ages from the lower 48 states, creating a database of more than 100,000 archaeological, geological, and paleontological ages that will be freely available to researchers through the Canadian Archaeological Radiocarbon Database. Here, we discuss the process used to compile ages, general characteristics of the database, and lessons learned from this exercise in “big data” compilation.

Precise instrumental calibration is of crucial importance to 21-cm cosmology experiments. The Murchison Widefield Array’s (MWA) Phase II compact configuration offers us opportunities for both redundant calibration and sky-based calibration algorithms; using the two in tandem is a potential approach to mitigate calibration errors caused by inaccurate sky models. The MWA Epoch of Reionization (EoR) experiment targets three patches of the sky (dubbed EoR0, EoR1, and EoR2) with deep observations. Previous work in Li et al. (2018) and (2019) studied the effect of tandem calibration on the EoR0 field and found that it yielded no significant improvement in the power spectrum (PS) over sky-based calibration alone. In this work, we apply similar techniques to the EoR1 field and find a distinct result: the improvements in the PS from tandem calibration are significant. To understand this result, we analyse both the calibration solutions themselves and the effects on the PS over three nights of EoR1 observations. We conclude that the presence of the bright radio galaxy Fornax A in EoR1 degrades the performance of sky-based calibration, which in turn enables redundant calibration to have a larger impact. These results suggest that redundant calibration can indeed mitigate some level of model incompleteness error.

Aerogels are light-weight porous materials that can tolerate the processing steps required for designing and creating an electric circuit such that the aerogel can be utilized as a substrate for device fabrication. Previous studies have shown the biostability and biocompatibility of polyurea crosslinked silica aerogels both in vivo and in vitro and have demonstrated the potential use of aerogels in biomedical applications. In vitro studies have shown that in the presence of an applied electric field neurites regeneration rate was greater on crosslinked silica aerogels than on tissue culture petridish used as a positive control. Currently, epineural suturing and nerve grafting are the gold standards for surgical reconstruction of injured nerves. However, because they rely on passive mechanisms for reapproximating the distal and proximal terminals they often lead to partial or no recovery leaving room for improvement. The present study investigates the feasibility of a wireless aerogel–based electrically-stimulating implant intended for nerve repair applications. Here the authors report on RF coupling between a secondary coil and a primary coil to wirelessly energize an interdigitated electrode array consisting of eleven interlocking fingers, created on a silica aerogel substrate. The coupling strength was tested both in air and in an animal model, as a function of distance and will be reported. This study focuses on in vivo evaluation and feasibility assessment of a novel active 3-D aerogel-based peripheral nerve repair device. The device utilizes induced EMF to establish a current (hence electrical stimulation) in predetermined pathways where nerve stumps will be confined to. Fundamental differences between in vitro and in vivo models necessitate the in vivo approach. The novel inductively-powered electrical stimulation aerogel-based device utilizes previously established 3-D confinement method for immobilization of nerve stumps, taking advantage of the mesoscopic surface roughness, unique to aerogels. The technique is tested on a mechanically strong, lightweight, porous, and biostable aerogel. Lithographic techniques, gold (Au) thin film metallization, and Faraday induction is used for circuit design, development, and activation.

OBJECTIVES/SPECIFIC AIMS: Morphea (localized scleroderma) is an autoimmune disease characterized that is widely thought to have a monophasic course, in which an initial period of inflammation (activity) ultimately results in scarring, atrophy, and functional impairment (damage). Understanding the long-term clinical course of morphea is important for the planning of future interventional studies, and as a tool for clinicians in determining risk for poor disease outcomes. METHODS/STUDY POPULATION: We conducted a prospective cohort study of 130 participants enrolled in the Morphea in Children and Adults Cohort over a median follow-up time of 4.3 years, to determine the rates of response to treatment and disease recurrence as measured by the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT). To determine risk factors for recurrence of disease activity, survival analysis using the log-rank test was used to compare subgroups by morphea type, therapy, and age at disease onset. RESULTS/ANTICIPATED RESULTS: Within a 1-year follow-up period, 66% of patients treated with methotrexate and 46% of patients with UVA1 phototherapy had achieved complete response to treatment. In patients who had achieved response to treatment, 29% experienced disease recurrence at an average of 1.7 years after documented disease inactivity. Patients with generalized morphea experienced higher recurrence rates than those with linear morphea (HR: 3.03, 95% CI: 1.48–6.22), and those treated with UVA1 phototherapy had higher recurrence over those treated with methotrexate (HR: 2.33, 95% CI: 1.03–5.31). In patients with follow-up periods longer than 5 years (n=50), disease recurrence was observed in 44% of patients and the majority of recurrence represented new activity in an area of pre-existing morphea (82%). DISCUSSION/SIGNIFICANCE OF IMPACT: This study highlights the previously under-studied dynamic long-term course of morphea, and identifies the clinical characteristics that predispose patients to having a relapsing-remitting course. We conclude that patients with morphea should be followed closely over time even in the absence of disease activity due to the potential for disease recurrence.